Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 27
ID1142ThPPIDTh1020NameAsparaginasePeptide SequenceQMSLQQELRYIEALSAIVET Full viewLength255Functional ClassificationIcDiseaseCancerBrandElsparCompanyMerck & Co. IncPhysical AppearanceLyophilized plug or powderRoute of AdministartionIntravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first.CategoryAntineoplastic Agents TargetL-asparagine
ID1201ThPPIDTh1026NameAnistreplasePeptide SequenceSYQVICRDEKTQMIYQQHQS Full viewLength255Functional ClassificationIcDiseaseHematological,MetabolicBrandEminaseCompanyWulfing Pharma GmbHPhysical AppearanceDry powderRoute of AdministartionIntravenous infusionCategoryThrombolytic Agents, Fibrinolytic agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1260ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandMyoblocCompanySolstice NeurosciencesPhysical AppearanceClear and colorless to light-yellow sterile injectable solutionRoute of AdministartionInjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1261ThPPIDTh1037NameBotulinum Toxin Type BPeptide SequenceMPVTINNFNYNDPIDNNNII Full viewLength255Functional ClassificationIcDiseaseNeurological DisorderBrandNeuroblocCompanySolstice NeurosciencesPhysical AppearanceClear and colourless to light yellow solutionRoute of AdministartionIntramuscular InjectionCategoryAntidystonic Agents TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1288ThPPIDTh1042NameCollagenasePeptide SequenceMKRKCLSKRLMLAITMATIF Full viewLength255Functional ClassificationIcDiseaseHematologicalBrandCordaseCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryN.A. TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain
ID1289ThPPIDTh1042NameCollagenasePeptide SequenceMKRKCLSKRLMLAITMATIF Full viewLength255Functional ClassificationIcDiseaseHematologicalBrandSantylCompanyAdvance Biofactures CorpPhysical AppearanceSterile enzymatic debriding ointmentRoute of AdministartionExternal use onlyCategoryN.A. TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain
ID1290ThPPIDTh1042NameCollagenasePeptide SequenceMKRKCLSKRLMLAITMATIF Full viewLength255Functional ClassificationIcDiseaseHematologicalBrandXiaflexCompanyAuxiliumPhysical AppearanceSterile lyophilized powder (white cake)Route of AdministartionIntralesional InjectionCategoryN.A. TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain
ID1305ThPPIDTh1043NameRasburicasePeptide SequenceSAVKAARYGKDNVRVYKVHK Full viewLength255Functional ClassificationIcDiseaseMetabolic/GeneticBrandElitekCompanySanofi-Synthelabo IncPhysical AppearanceSterile, white to off-white, lyophilized powderRoute of AdministartionIntravenous administrationCategoryAntihyperuricemic Agents, Gout suppressants TargetUric acid
ID1306ThPPIDTh1043NameRasburicasePeptide SequenceSAVKAARYGKDNVRVYKVHK Full viewLength255Functional ClassificationIcDiseaseMetabolic/GeneticBrandFasturtecCompanyN.A.Physical AppearancePowder and solvent that are made upto make solution.Route of AdministartionIntravenous administartionCategoryAntihyperuricemic Agents, Gout suppressants TargetUric acid
ID1316ThPPIDTh1044NameAdalimumabPeptide SequenceLight-chain:DIQMTQS< Full viewLength230Functional ClassificationIcDiseaseImmunologicalBrandHumiraCompanyAbbott LaboratoriesPhysical AppearanceSterile, preservative-free solutionRoute of AdministartionSubcutaneous administrationCategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1317ThPPIDTh1044NameAdalimumabPeptide SequenceLight-chain:DIQMTQS< Full viewLength230Functional ClassificationIcDiseaseOsteologicalBrandHumira PenCompanyAbbott LaboratoriesPhysical AppearanceSterile, preservative-free solutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1337ThPPIDTh1048NamePegaspargasePeptide SequenceMEFFKKTALAALVMGFSGAA Full viewLength255Functional ClassificationIcDiseaseCancerBrandOncasparCompanyEnzon IncPhysical AppearanceSolutionRoute of AdministartionIntravenous or Intramuscular administrationCategoryAntineoplastic Agents TargetL-asparagine
ID1381ThPPIDTh1059NameHyaluronidasePeptide SequenceMWTGLGPAVTLALVLVVAWA Full viewLength476Functional ClassificationIcDiseaseAdjunct TherapyBrandHYLENEXCompanyBaxter Healthcare CorporationPhysical AppearanceSterile, clear, colorless, nonpreserved, ready for use solution.Route of AdministartionHuman Injection Subcutaneous useCategoryAdjuvants, Anesthesia and Permeabilizing Agents TargetN.A.
ID1419ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandBOTOX CompanyAllerganPhysical AppearanceSterile, vacuum-dried purified botulinum toxin type A, produced from fermentation of Hall strainClostridium botulinum type ARoute of AdministartionIntramuscular, intradetrusor and intradermal useCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1420ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandDysportCompanyIpsen PharmaceuticalsPhysical AppearanceSterile vial for reconstitutionRoute of AdministartionIntramuscular InjectionCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1421ThPPIDTh1070NameBotulinum Toxin Type APeptide SequenceMPFVNKQFNYKDPVNGVDIA Full viewLength1296Functional ClassificationIcDiseaseNeurological DisorderBrandXeominCompanyMERZ AESTHETICSPhysical AppearanceSterile white to off-white lyophilized powder after reconstitution with preservative-free 0.9% Saline for Injection.Route of AdministartionIntramuscular InjectionCategoryNeuromuscular Blocking Agents, Anti-Wrinkle Agents and Antidystonic Agents TargetGrowth hormone receptor
ID1428ThPPIDTh1072NameStreptokinasePeptide SequenceMKNYLSFGMFALLFALTFGT Full viewLength440Functional ClassificationIcDiseaseMetabolic/HaemetologicalBrandStreptaseCompanyCSL BehringPhysical AppearanceSterile, purified preparation formulated as lypholized powderRoute of AdministartionIntravenous and intracoronary administration.CategoryFibrinolytic Agents and Thrombolytic Agents TargetN.A.
ID1477ThPPIDTh1097NameAlglucosidase AlfaPeptide SequenceAHPGRPRAVPTQCDVPPNSR Full viewLength882Functional ClassificationIcDiseaseMetabolicBrandLUMIZYMECompanyGenzymePhysical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with 10.3 Ml Sterile Water for Injection, USPRoute of AdministartionIntravenous infusionCategoryEnzyme Replacement Agents TargetCation-dependent mannose-6-phosphate receptor,Glycogen
ID1621ThPPIDTh1134NameAsparaginase Erwinia ChrysanthemiPeptide SequenceADKLPNIVILATGGTIAGSA Full viewLength327Functional ClassificationIcDiseaseHormonalBrandErwinazeCompanyEUSA PharmaPhysical AppearanceSterile, lyophilized, white powder in vials.Route of AdministartionIntramuscular injectionCategoryEnzymes TargetN.A.
ID1622ThPPIDTh1135NameOcriplasminPeptide SequenceTruncated heavy chai Full viewLength251Functional ClassificationIcDiseaseEye DisorderBrandJetreaCompanyThromboGenics NVPhysical AppearanceSterile, clear and colorless solution with no preservativesRoute of AdministartionIntravitreal injectionCategoryOphthalmics TargetFibronectin,Alpha-2-macroglobulin,Alpha-2-antiplasmin
ID1623ThPPIDTh1136NameGlucarpidasePeptide SequenceALAQKRDNVLFQAATDEQPA Full viewLength393Functional ClassificationIcDiseaseHormonalBrandVoraxazeCompanyBTG InternationalPhysical AppearanceSterile, preservative-free, white lyophilized powder in single-use vialsRoute of AdministartionIntravenous injectionCategoryEnzymes TargetMethotrexate
ID1637ThPPIDTh1143NameFibrinolysin Aka PlasminPeptide SequenceFibrinolysin heavy c Full viewLength786Functional ClassificationIcDiseaseHematologicalBrandElaseCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryN.A. TargetN.A.
ID1678ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis U.S. LlcPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 9
ID1679ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 10
ID1680ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis Canada IncPhysical AppearanceSolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 11
ID1681ThPPIDTh1162NameAlirocumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseMetabolic/CardiacBrandPraluentCompanySanofi Aventis U.S. LlcPhysical AppearanceInjection, SolutionRoute of AdministartionSubcutaneousCategoryN.A. TargetProprotein convertase subtilisin/kexin type 14
ID1820ThPPIDTh1211NameIxekizumabPeptide SequenceNA Full viewLength0Functional ClassificationIcDiseaseInfectious DiseaseBrandTaltzCompanyEli lillyPhysical AppearanceSterile, preservative free, clear and colorless to slightly yellow SolutionRoute of AdministartionSubcutaneousCategoryNA TargetNA